Prof Says Ex-SAC Manager Got Details On Drug Study

Law360, New York (January 21, 2014, 8:46 PM EST) -- A former university professor testified Tuesday that he provided ex-SAC Capital Advisors LP portfolio manager Mathew Martoma final details on an Alzheimer’s drug study, expanding on testimony he offered in Manhattan federal court last week.

Sidney Gilman told jurors that he provided Martoma with the final safety committee report on a the drug bapineuzumab, building on testimony he offered Friday.

Gilman, a former University of Michigan professor who chaired the drug’s safety committee, is widely considered the star witness in the case against Martoma, a former...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.